spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

US-Japan trade deal guarantees lowest tariff rates for chips, pharma, Japanese official says

Japan’s leading trade negotiator said on Tuesday that the trade deal Tokyo agreed with the United States last week guarantees Japan will always receive the lowest tariff rate on chips and pharmaceuticals of all the pacts negotiated by Washington.

“If a third country agrees with the United States on lower rates on chips and pharmaceuticals, those lower rates would apply to Japan,” Ryosei Akazawa told a news conference.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The European Union secured a 15% baseline tariff as part of a framework trade deal with the U.S. this week, averting looming new tariffs on chips and pharmaceuticals.

Japan last week struck a trade deal with the U.S. that lowers tariffs on cars and other goods to 15% in exchange for a U.S.-bound $550 billion Japanese investment package including equity, loans and guarantees.

Asked why there has been no joint statement on the agreement, Akazawa said Japan is prioritising having President Donald Trump sign an executive order to bring the agreed 15% tariff rate into effect.

“We want to concentrate our efforts on getting the tariffs lowered first, and then we can consider whether an official document on the agreement is necessary,” he said.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img